JEFFREY PIRTLE: Open Payments
NPI 1740357177 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,941 in 128 payments from 14 companies in 2025. Trend: 2023 $1,337 · 2024 $1,676 · 2025 $2,941
Food & beverage: $2,090Consulting: $740Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 28 | $1,207 |
| Alkermes, Inc. | 18 | $456 |
| Indivior Inc. | 12 | $274 |
| Otsuka America Pharmaceutical, Inc. | 23 | $244 |
| Teva Pharmaceuticals USA, Inc. | 16 | $241 |
| Vanda Pharmaceuticals Inc. | 10 | $154 |
| Neurocrine BioSciences, Inc. | 7 | $122 |
| Braeburn Inc. | 3 | $60 |
| Lundbeck LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
Products named: COBENFY, SUBLOCADE, ARISTADA, REXULTI, FANAPT, LYBALVI, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
